Shouzheng Innovation Tell the Chinese story "The study of mulberry alkaloids in China and the West" academic seminar.

On September 19th, the Chinese Academy of Medical Sciences and the Institute of Pharmaceuticals of the Beijing Concord Medical College held an academic seminar on "Shouzheng Innovation and Telling the Chinese Story - The Study of Sangzhi Alkaloids in China and the West" in the Auditorium of the Concord Medical College in Beijing.
Vice Chairman of the CPPCC National Committee, Executive Vice Chairman of the Central Committee of the Agricultural and Labour Party He Wei, "People's Hero" National Honorary Title Winner, Chinese Academy of Engineering Academician Zhang Boli, Chairman of the Chinese Pharmaceutical Society Sun Xianze, Deputy Director of the Science and Education Department of the National Health and Health Commission Chen Wei, Chinese Academy of Engineering Academician Baden, Chinese Academy of Engineering Academician Liu Depei, Chinese Academy of Sciences Academician Qiang Boqin, National Health and Health Commission Science and Technology Development Center Director Zheng Zhongwei, China Pharmaceutical Association Director Zhang Yong Rui Wei, Director of the Science and Technology Association Center of the Beijing Municipal Science and Technology Commission Lei Wei, Director of the Biomedical Base of Daxing District of Beijing, Tian Dexiang, Vice President of the Beijing Concord Medical College of the Chinese Academy of Medical Sciences Zhang Qin, Vice President of the Beijing Concord Medical College of the Chinese Academy of Medical Sciences Wang Jianwei, relevant departments of the Beijing Municipal Science and Technology Commission, many well-known clinical experts, heads of institutions and system departments and cooperative enterprises, as well as the Chinese Academy of Medical Sciences Pharmaceutical Research Institute, old leaders, old experts, teachers and other 150 people attended the meeting.
conference was presided over by Yu Shishan, Deputy Director of the Institute of Drugs, and delivered a welcoming speech.
conference, Jiang Jiandong, director of the Institute of Drugs, first introduced the general truth of drug research: man and nature.
He proposed that plants, animals, microorganisms make up the world we live in, is the insincexed source of human health, ephedrine, artificial musk, penicillin and other drugs research originated here, the same is true of mulberry alkaloids, hope that participants for human health to put forward scientific insights.
attendees watched the feature film "Hold on to the March - The Chinese Story of "Keeping The Right Innovation" in the research and development of Sangzhi Alkaloids.
"a belief, a culture, a model", "Sanzhi total alkaloid" research and development process touched everyone present, let everyone feel the power of scientific and technological innovation.
On the basis of the early work of the older generation of pharmacologist Xie Wise Researcher, led by Liu Yuling Researcher and Shen Zhufang Researcher of the Institute of Pharmacology of the Chinese Academy of Medical Sciences, the original natural drug "Sanzhi Total Alkaloid", which took decades to develop, was approved for listing on March 17, 2020, with the adaptive disorder being "Type 2 Diabetes" (classified as a new class 5 chinese medicine by the old version of registration, classified as a class 1 chinese medicine by newly revised registration).
total alkaloid is a by-product of mulberry silkworm breeding "sanzhi" as a medicinal herbs, waste into treasure, supported by modern science and technology, extracted from the separation of the effective alkaloid parts.
for the treatment of type 2 diabetes, the material basis is clear, the mechanism of action is clear, in addition to reducing intestinal glucosaccharin production, delaying glucose absorption, but also has the regulation of glycolipid metabolism, improve intestinal micro-ecology, promote GLP-1 secretion, protect islet β cells and other multiple pharmacological effects.
Led by Beijing Concord Hospital, 31 clinical institutions participated in the internationally recognized standard of glycoglobin gold, completed the comparison with placebo and first-line drug head-to-head comparison of random double-blind thousands of large-sample clinical studies, established a new concept of clinical evaluation of Chinese medicine blood sugar.
the total alkaloids alone, we can achieve high-intensity glycation hemoglobin and hypoglycemia effect, changing the past Chinese medicine blood sugar can only be used as an auxiliary drug situation.
In addition, it can significantly improve the symptoms of patients with hypothermal internal heat and wet fever trapped spleen, regulate lipid metabolism, control weight, safety is significantly higher than chemical control drugs, both chemical anti-glycation hemoglobin and traditional Chinese medicine to improve the comprehensive advantages of traditional Chinese medicine, for carbohydrate-based Asian diabetics, or new diabetics, is expected to become the preferred drug for post-meal blood sugar control.
, Vice President He Wei expressed his heartfelt congratulations on the outstanding achievements made in the field of new drug research and development. My sincere greetings to the scientists and scientists who are fighting on the front line.
He pointed out that the success of the development of total alkaloids, which embodies three characteristics, one is in line with the modern medicine target-based development model;
that in the new historical period, the majority of medical workers will provide more solid protection for the people's high-quality life and make new contributions to the new journey of building a modern socialist medical power.
Sun Xianze, President of the Chinese Pharmaceutical Society, Chen Wei, Deputy Director of the Science and Education Department of the National Health and Health Commission, Bad Ian, Member of the Chinese Academy of Engineering, and Zhang Qin, Vice Dean of the Beijing Concord Medical College of the Chinese Academy of Medical Sciences, delivered speeches respectively.
Chairman Sun Xianze said that Sangzhi total alkaloid provides us with the practice of the essence of inheritance, the case of positive innovation, hope that the drug will bear in mind that General Secretary Xi Jinping "adheres to the world's scientific and technological frontier, facing the main economic battlefield, facing the country's major needs and facing people's life and health, and constantly marching into the breadth and depth of science and technology", for Chinese medicine scientific and technological innovation, better serve the health of citizens play an active role.
Deputy Director Chen Wei said that, as a landmark achievement in the field of Chinese medicine with major scientific and technological projects, the success of the "Sanzhi Total Alkaloid" in the "13th Five-Year Plan" of the new drug creation was gratifying.
Twelve years of implementation of major special projects for the creation of new drugs, China's drug research and development innovation capacity has made great progress, a number of major key technologies have made breakthroughs, look forward to the vast number of scientific researchers can continue to develop good drugs, new drugs, to help healthy China's construction.
, he extended warm congratulations to the comrades of the Drug Institute and the research and development group of "Sanzhi General Alkaloid".
pointed out that as the Chinese Academy of Medical Sciences, which really provides the most medicines for the Chinese people, the drug research group should form a fist, step up efforts and take on more heavy tasks.
the Academy of Medical Sciences to give full play to the role of the core base and make greater contributions to the modernization of Chinese medicine in China.
, vice president of the Chinese Academy of Medical Sciences, as China's top medical scientific research institution, has actively promoted the implementation of the spirit of General Secretary Xi Jinping's directive.
research staff of the
Pharmaceutical Institute after more than 20 years of research, ushered in the successful listing of Sangzhi total alkaloid, is China's pharmaceutical research and development in the field to seize the opportunity, independent innovation, to achieve the case of corner oversized.
meeting ushered in an exciting moment, the participants with the pot of hope watering, lit the tree of hope, witnessed the original innovative Chinese medicine "Sanzhi total alkaloid" results on the market.
Zhang Boli said, "Sanzhi total alkaloid" is a major special focus to support the project and landmark results, to the product launch and research team to congratulate.
he made a theme report on "Promoting the Spirit of Epidemic Resistance and Firm Cultural Self-Confidence", which described the important role played by Chinese medicine and Chinese medicine in the fight against the epidemic during the period in Wuhan, reflecting the clinical value of Chinese medicine in the prevention and treatment of major diseases.
also invited Liang Xiaochun, a professor at Beijing Concord Hospital, and Ji Linon, a professor at Peking University People's Hospital, to make wonderful academic reports on "Clinical Research on Sangzhi Total Alkaloid Tablets" and "The Advantages and Prospects of Natural Drug Treatment of Diabetes" respectively.
Finally, Wang Jianwei, vice president of the Beijing Concord Medical College of the Chinese Academy of Medical Sciences, made a concluding speech, stressing that the successful listing of "Sanzhi Total Alkaloid" is a new starting point on the road to the construction of the core base of the institutions, and hoped that the scientific and technological personnel of the colleges and universities will earnestly carry out the spirit of General Secretary Xi Jinping's important instructions, and that the research and development team will "sit on the bench for ten years cold" spirit, and work with one heart to push the scientific and technological innovation work of the institutions to a new height.
seminar, taking the listing of "Sanzhi Total Alkaloid" as an opportunity, discussed the research and development model and cultural connotation of the creation of new drugs with Chinese characteristics.
the administration of a new drug was approved for listing is only the beginning, medicine endless.
In the new era, drug companies will earnestly implement the decision-making and deployment of the CPC Central Committee and the State Council, implement the innovation-driven development strategy, respect nature, follow scientific laws, respect knowledge, respect talent, respect for creativity, respect for the strugglers of quiet distance, promote the continuous emergence of scientific and technological innovation, and contribute to the realization of the great rejuvenation of the Chinese dream of the Chinese nation!